The US Department of Health and Human Services (HHS) is struggling to limit cyber threats in the healthcare sector as it has not implemented previous recommendations made by the Government Accountability Office (GAO) such as monitoring ransom-specific cyber practices and assessing risks from operational and internet of things devices. This puts patient care at risk and could prevent the HHS from leading in industry cybersecurity, the GAO said.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
